Lupin receives FDA approval for generic Topicort Topical Spray, 0.25%.

From USFDA

Lupin has received final approval for its Desoximetasone Topical Spray, 0.25%, 30 ml, 50 ml and 100 ml from the USFDA to market a generic version of Taro Pharmaceuticals USA Inc.'s Topicort Topical Spray, 0.25%. It is a corticosteroid indicated for the treatment of plaque psoriasis in patients 18 years of age or older.

Powered by Capital Market - Live News